​

Funding Round

Series B - May Health

Series B - May Health

Investment Firm

Overview

May Health develops an innovative solution for Polycystic Ovary Syndrome (PCOS) related infertility.

Announced Date

May 13, 2024

Funding Type

Series B

Highlights

Location

Europe

Social

Investor Lead

Bpifrance

Bpifrance

Bpifrance is a debt and early_stage_venture and grant and private_equity and seed firm.

Trill Impact

Trill Impact

Trill Impact is a early_stage_venture and private_equity firm.

Participant Investors

5

Investor Name
Participant InvestorKidron
Participant InvestorAvestria Ventures
Participant InvestorTrill Impact
Participant InvestorSofinnova Partners
Participant InvestorBpifrance

Round Details and Background

May Health raised $24821822 on 2024-05-13 in Series B

May Health develops an innovative solution for Polycystic Ovary Syndrome (PCOS) related infertility.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jul 09, 2019
Series A - May Health
1-11.2M
Sep 17, 2018
Seed Round - May Health
1-undefined
May 13, 2024
Series B - May Health
5-24.8M

Recent Activity

There is no recent news or activity for this profile.